CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 34 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $4,000 | -20.0% | 12,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $5,000 | +25.0% | 12,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $4,000 | +33.3% | 12,000 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | -76.9% | 12,000 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $13,000 | -38.1% | 12,000 | 0.0% | 0.00% | -33.3% |
Q4 2018 | $21,000 | – | 12,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kalos Management, Inc. | 47,500 | $12,000 | 0.01% |
Virtu Financial LLC | 94,842 | $25,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 467,425 | $121,000 | 0.00% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $6,000 | 0.00% |
A.R.T. Advisors, LLC | 60,430 | $16,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 25,350 | $7,000 | 0.00% |
MORGAN STANLEY | 1,019 | $0 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $6,000 | 0.00% |
WOLVERINE TRADING, LLC | 30,900 | $8,000 | 0.00% |
WOLVERINE TRADING, LLC | 26,779 | $7,000 | 0.00% |